Rezo Therapeutics

About

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

South San Francisco,California,United States
1 - 10
https://www.rezotx.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $78M
Industries: Biotechnology,Product Research
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: Rezo Therapeutics, Inc.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$78M

Rezo Therapeutics has raised a total of $78M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 17, 2022	Series A	$78M	9	Norwest Venture Partners Andreessen Horowitz SR One	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

9

Rezo Therapeutics is funded by 9 investors. Norwest Venture Partners and Andreessen Horowitz are the most recent investors.

Investor Name	Lead Investor	Funding Round
Norwest Venture Partners	Yes	Series A
Andreessen Horowitz	Yes	Series A
SR One	Yes	Series A
Alexandria Venture Investments	—	Series A
Eli Lilly	—	Series A
Hawktail Management	—	Series A
Liquid 2 Ventures	—	Series A
SVA	—	Series A
UCSF Foundation Investment Company	—	Series A